115 related articles for article (PubMed ID: 15852178)
21. New applications of thyroid and parathyroid ultrasound.
Baskin HJ
Minerva Endocrinol; 2004 Dec; 29(4):195-206. PubMed ID: 15765029
[TBL] [Abstract][Full Text] [Related]
22. Sonography of the thyroid and parathyroid glands.
Gritzmann N; Koischwitz D; Rettenbacher T
Radiol Clin North Am; 2000 Sep; 38(5):1131-45, xii. PubMed ID: 11054973
[TBL] [Abstract][Full Text] [Related]
23. Ethanol injection to parathyroid tissue: indications and limitations.
Khafif A; Halperin D; Marshak G
Ear Nose Throat J; 1998 Jul; 77(7):538-40. PubMed ID: 9693469
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800
[TBL] [Abstract][Full Text] [Related]
25. Histological study of papillary thyroid carcinoma treated with percutaneous ethanol injection therapy.
Akasu H; Shimizu K; Kitagawa W; Naito Z; Kawanami O; Tanaka S
Pathol Int; 2002; 52(5-6):406-9. PubMed ID: 12100524
[TBL] [Abstract][Full Text] [Related]
26. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
Uemura K; Kakuta T
Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
[TBL] [Abstract][Full Text] [Related]
27. [Non-real-time computed tomography-guided percutaneous ethanol injection therapy for hepatocellular carcinoma undetectable by ultrasonography].
Ueda K; Ohkawara T; Minami M; Sawa Y; Morinaga O; Kohli Y; Ohkawara Y
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1254-8. PubMed ID: 9703802
[TBL] [Abstract][Full Text] [Related]
28. ULTRASOUND-GUIDED PERCUTANEOUS ETHANOL INJECTION THERAPY IN A 92 YEAR-OLD PATIENT WITH PARATHYROID ADENOMA AND WITH A HISTORY OF TOTAL THYROIDECTOMY FOR PAPILLARY THYROID CARCINOMA.
Halenka M; Frysak Z; Koranda P; Schovanek J
Acta Endocrinol (Buchar); 2016; 12(3):349-354. PubMed ID: 31149113
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound-guided percutaneous ethanol ablation of parathyroid hyperplasia: preliminary experience in patients on chronic dialysis.
Schamp S; Dünser E; Schuster H; Kramer-Deimer J; Kettenbach J; Funovics M; Lang U; Meisl FT; Umek H
Ultraschall Med; 2004 Apr; 25(2):131-6. PubMed ID: 15085455
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism.
Wada A; Sugihara M; Sugimura K; Kuroda H
Radiat Med; 1999; 17(4):275-82. PubMed ID: 10510900
[TBL] [Abstract][Full Text] [Related]
32. Changes in radioiodine turnover in patients with autonomous thyroid adenoma treated with percutaneous ethanol injection.
Paracchi A; Reschini E; Ferrari C; Ciocia G; Castellani M
J Nucl Med; 1998 Jun; 39(6):1012-6. PubMed ID: 9627335
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous ethanol injection treatment of autonomous thyroid adenoma: hormonal and clinical evaluation.
Monzani F; Goletti O; Caraccio N; Del Guerra P; Ferdeghini M; Pucci E; Baschieri L
Clin Endocrinol (Oxf); 1992 May; 36(5):491-7. PubMed ID: 1617800
[TBL] [Abstract][Full Text] [Related]
34. Long-term efficacy evaluation of a protocol for the management of symptomatic thyroid cysts with ultrasound-guided percutaneous ethanol injection.
Reverter JL; Vázquez F; Puig-Jové C; Oca AP; Puig-Domingo M
Endocrinol Diabetes Nutr (Engl Ed); 2021 Apr; 68(4):236-242. PubMed ID: 34266635
[TBL] [Abstract][Full Text] [Related]
35. A case of post-transplant hyperparathyroidism treated with ethanol injection.
Ohta T; Sakano T; Fuchinoue S; Tsuji T; Tanabe K; Hattori M; Nagafuchi H; Shiraga H; Kihara H; Kinoshita Y; Ito K
Pediatr Nephrol; 2002 Apr; 17(4):236-8. PubMed ID: 11956872
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidism.
Douthat WG; Orozco SE; Maino P; Cardozo G; de Arteaga J; de la Fuente J; Chiurchiu CR; Massari PU
Transpl Int; 2007 Dec; 20(12):1031-5. PubMed ID: 17883371
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous ethanol injection therapy as the first line of treatment of symptomatic thyroid cysts.
Merchante Alfaro AÁ; Garzón Pastor S; Pérez Naranjo S; González Boillos M; Blanco Dacal J; Maravall Royo FJ; Abellán Galiana P; Morillas Ariño C
Endocrinol Diabetes Nutr (Engl Ed); 2021; 68(7):458-464. PubMed ID: 34863410
[TBL] [Abstract][Full Text] [Related]
38. Safe and effective percutaneous ethanol injection therapy of 200 thyroid cysts.
Halenka M; Karasek D; Schovanek J; Frysak Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun; 164(2):161-167. PubMed ID: 30945701
[TBL] [Abstract][Full Text] [Related]
39. Ethanol ablation of thyroid cysts in the young with a focus on efficacy and quality of life.
Halenka M; Munteanu H; Obereigneru R; Dohnal R; Karasek D; Schovanek J
Eur Thyroid J; 2023 Aug; 12(5):. PubMed ID: 37432713
[TBL] [Abstract][Full Text] [Related]
40. Medical management after parathyroid intervention.
Tanaka M; Fukagawa M
NDT Plus; 2008 Aug; 1(Suppl 3):iii18-iii20. PubMed ID: 25983966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
